7.04
전일 마감가:
$7.26
열려 있는:
$7.29
하루 거래량:
94,268
Relative Volume:
0.44
시가총액:
$75.01M
수익:
$1.54M
순이익/손실:
$-38.70M
주가수익비율:
-1.5075
EPS:
-4.67
순현금흐름:
$-36.86M
1주 성능:
+14.85%
1개월 성능:
+21.38%
6개월 성능:
-59.89%
1년 성능:
-83.62%
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Company Profile
명칭
Corbus Pharmaceuticals Holdings Inc
전화
617-963-0103
주소
500 RIVER RIDGE DRIVE, NORWOOD, MA
CRBP을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
CRBP
Corbus Pharmaceuticals Holdings Inc
|
7.04 | 75.01M | 1.54M | -38.70M | -36.86M | -4.67 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
421.16 | 111.66B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
571.36 | 60.56B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ARGX
Argen X Se Adr
|
532.27 | 38.04B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
267.55 | 36.06B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ONC
Beigene Ltd Adr
|
219.95 | 25.10B | 3.81B | -644.79M | -669.77M | -6.24 |
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-02-28 | 개시 | William Blair | Outperform |
2024-12-02 | 개시 | Piper Sandler | Overweight |
2024-07-30 | 개시 | Wedbush | Outperform |
2024-07-22 | 재개 | H.C. Wainwright | Buy |
2024-06-26 | 개시 | B. Riley Securities | Buy |
2024-06-03 | 재확인 | Oppenheimer | Outperform |
2024-05-13 | 개시 | RBC Capital Mkts | Outperform |
2024-03-06 | 업그레이드 | Jefferies | Hold → Buy |
2020-09-08 | 다운그레이드 | BTIG Research | Buy → Neutral |
2020-09-08 | 다운그레이드 | Jefferies | Buy → Hold |
2020-09-08 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
2020-09-08 | 다운그레이드 | ROTH Capital | Buy → Neutral |
2020-07-07 | 개시 | ROTH Capital | Buy |
2020-06-17 | 개시 | BTIG Research | Buy |
2020-03-26 | 개시 | Nomura | Buy |
2019-04-05 | 개시 | Jefferies | Buy |
2019-03-20 | 개시 | Oppenheimer | Outperform |
2019-01-11 | 재확인 | Cantor Fitzgerald | Overweight |
2018-12-26 | 개시 | H.C. Wainwright | Buy |
2018-12-07 | 개시 | RBC Capital Mkts | Outperform |
2018-10-24 | 개시 | B. Riley FBR | Buy |
2018-01-19 | 개시 | Raymond James | Outperform |
2017-12-14 | 재확인 | Cantor Fitzgerald | Overweight |
2017-11-08 | 재확인 | Noble Financial | Buy |
2017-09-29 | 재개 | Noble Financial | Buy |
2017-03-30 | 재확인 | Cantor Fitzgerald | Overweight |
2016-11-15 | 재확인 | JMP Securities | Mkt Outperform |
2016-11-11 | 재확인 | Noble Financial | Buy |
모두보기
Corbus Pharmaceuticals Holdings Inc 주식(CRBP)의 최신 뉴스
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Shares Sold by Barclays PLC - Defense World
Wells Fargo & Company MN Has $76,000 Holdings in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Shares Sold by Tower Research Capital LLC TRC - Defense World
Oppenheimer Cuts Corbus Pharmaceuticals (NASDAQ:CRBP) Price Target to $56.00 - Defense World
B. Riley Expects Reduced Earnings for Corbus Pharmaceuticals - Defense World
HC Wainwright Cuts Corbus Pharmaceuticals (NASDAQ:CRBP) Price Target to $40.00 - Defense World
Wedbush Expects Weaker Earnings for Corbus Pharmaceuticals - Defense World
Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
Royal Bank of Canada Has Lowered Expectations for Corbus Pharmaceuticals (NASDAQ:CRBP) Stock Price - Defense World
Corbus Pharmaceuticals to Present at the 2025 RBC Capital Markets Global Healthcare Conference - GlobeNewswire
Cannabis Stock Tilray Brands Loses 19% in a Month: Time to Sell or Hold? - Zacks Investment Research
Corbus Pharmaceuticals Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
CRBP: RBC Capital Lowers Price Target, Maintains Outperform Rati - GuruFocus
Oppenheimer Lowers Price Target for Corbus Pharmaceuticals (CRBP) | CRBP Stock News - GuruFocus
Corbus Pharmaceuticals (CRBP) Target Price Reduced by Analyst | CRBP Stock News - GuruFocus
Corbus Pharmaceuticals (CRBP) Target Price Adjusted by RBC Capital | CRBP Stock News - GuruFocus
CRBP: HC Wainwright & Co. Lowers Price Target for Corbus Pharmaceuticals | CRBP Stock News - GuruFocus
Oppenheimer Adjusts Price Target for Corbus Pharmaceuticals (CRBP) | CRBP Stock News - GuruFocus
RBC Cuts Price Target on Corbus Pharmaceuticals Holdings to $58 From $65, Keeps Outperform, Speculative Risk - marketscreener.com
Corbus Pharmaceuticals (CRBP) Sees Price Target Reduction | CRBP Stock News - GuruFocus
Corbus Pharmaceuticals: Q1 Earnings Snapshot - CTPost
Corbus Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides a Corporate Update - GlobeNewswire
Corbus Pharmaceuticals Advances Clinical Pipeline Amid Q1 Loss - TipRanks
Corbus Pharmaceuticals (CRBP) Advances Pipeline with Promising E - GuruFocus
Corbus Pharmaceuticals Receives FDA Fast Track Designation - TipRanks
Corbus Pharmaceuticals (CRBP) Advances Pipeline with Promising Early Trial Data | CRBP Stock News - GuruFocus
Corbus Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits - Quantisnow
Corbus Pharmaceuticals Secures FDA Fast Track for Cancer Drug as 3 Clinical Programs Hit Key Milestones - Stock Titan
Trading (CRBP) With Integrated Risk Controls - news.stocktradersdaily.com
Corbus Pharmaceuticals (CRBP) to Release Quarterly Earnings on Tuesday - Defense World
Corbus Pharmaceuticals Holdings Inc expected to post a loss of $1.28 a shareEarnings Preview - TradingView
3 Unconventional Cannabis Stocks to Watch in 2025 - Zacks Investment Research
Geode Capital Management LLC Acquires 13,773 Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World
Corbus Pharmaceuticals Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Receives $59.13 Average Price Target from Analysts - American Banking and Market News
Press Release Distribution & PR Platform - ACCESS Newswire
Brokerages Set Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) PT at $59.13 - Defense World
Corbus Pharmaceuticals Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch
Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
(CRBP) Trading Report - news.stocktradersdaily.com
We Think Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) Can Afford To Drive Business Growth - Yahoo Finance
Wall Street Analysts See a 764.18% Upside in Corbus Pharmaceuticals (CRBP): Can the Stock Really Move This High? - Yahoo Finance
CRBP stock touches 52-week low at $4.64 amid sharp annual decline - Investing.com
CRBP stock touches 52-week low at $4.64 amid sharp annual decline By Investing.com - Investing.com South Africa
Where are the Opportunities in (CRBP) - news.stocktradersdaily.com
Corbus Pharmaceuticals Holdings Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Corbus Pharmaceuticals Holdings Inc (CRBP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):